Ret finger protein inhibits muscle differentiation by modulating serum response factor and enhancer of polycomb1

Cell Death and Differentiation

Volumn 19, Issue 1, 2012, Pages 121-131

  Kee, H J ^a,b   Kim, J R ^a,g   Joung, H ^a   Choe, N ^a   Lee, S E ^a   Eom, G H ^a   Kim, J C ^b   Geyer, S H ^c   Jijiwa, M ^d   Kato, T ^d   Kawai, K ^e   Weninger, W J ^c   Seo, S B ^f   Nam, K I ^a   Jeong, M H ^b   Takahashi, M ^d   Kook, H ^a,b  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

^f Chung Ang University   (South Korea)

^g University School of Medicine   (United States)

Author keywords

enhancer of polycomb1; muscle differentiation; ret finger protein; serum response factor

Indexed keywords

ALPHA ACTIN; ENHANCER OF POLYCOMB1 PROTEIN; POLYCOMB GROUP PROTEIN; PROTEIN; RET FINGER PROTEIN; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; GENE ACTIVATION; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SERUM RESPONSIVE ELEMENT;

ACTINS; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, KNOCKOUT; MUSCLE CELLS; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MYOBLASTS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

MUS;

EID: 84856752714     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.72     Document Type: Article

References (37)

1. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20: 2140-2151. (Pubitemid 32410584)
2. Borden KL. RING fingers and B-boxes: zinc-binding protein-protein interaction domains. Biochem Cell Biol 1998; 76: 351-358. (Pubitemid 29102020)
3. Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E et al. Acute promyelocytic leukemia: from genetics to treatment. Blood 1994; 83: 10-25. (Pubitemid 24016510)
4. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat P et al. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995; 14: 2020-2033.
5. Takahashi M, Cooper GM. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol Cell Biol 1987; 7: 1378-1385. (Pubitemid 17045226)
6. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell 1985; 42: 581-588. (Pubitemid 16091150)
7. Takahashi M, Inaguma Y, Hiai H, Hirose F. Developmentally regulated expression of a human "finger"-containing gene encoded by the 50 half of the ret transforming gene. Mol Cell Biol 1988; 8: 1853-1856.
8. Klugbauer S, Rabes HM. The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 1999; 18: 4388-4393. (Pubitemid 29392380)
9. Chang KS, Stass SA, Chu DT, Deaven LL, Trujillo JM, Freireich EJ. Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia. Mol Cell Biol 1992; 12: 800-810.
10. Borrow J, Goddard AD, Sheer D, Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science 1990; 249: 1577-1580.
11. Cao T, Duprez E, Borden KL, Freemont PS, Etkin LD. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML. J Cell Sci 1998; 111 (Part 10): 1319-1329. (Pubitemid 28274384)
12. Morris-Desbois C, Bochard V, Reynaud C, Jalinot P. Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies. J Cell Sci 1999; 112 (Part 19): 3331-3342. (Pubitemid 29507213)
13. Shimono Y, Murakami H, Hasegawa Y, Takahashi M. RET finger protein is a transcriptional repressor and interacts with enhancer of polycomb that has dual transcriptional functions. J Biol Chem 2000; 275: 39411-39419. (Pubitemid 32058965)
14. Kim JR, Kee HJ, Kim JY, Joung H, Nam KI, Eom GH et al. Enhancer of polycomb1 acts on serum response factor to regulate skeletal muscle differentiation. J Biol Chem 2009; 284: 16308-16316.
15. Jo C, Jang BG, Jo SA. MEK1 plays contrary stage-specific roles in skeletal myogenic differentiation. Cell Signal 2009; 21: 1910-1917.
16. Kee HJ, Kim JR, Nam KI, Park HY, Shin S, Kim JC et al. Enhancer of polycomb1, a novel homeodomain only protein-binding partner, induces skeletal muscle differentiation. J Biol Chem 2007; 282: 7700-7709. (Pubitemid 47093707)
17. Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem 1999; 274: 29063-29070.
18. Kato T, Shimono Y, Hasegawa M, Jijiwa M, Enomoto A, Asai N et al. Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress. Cancer Res 2009; 69: 3597-3604.
19. Karsch-Mizrachi I, Travis M, Blau H, Leinwand LA. Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene. Nucleic Acids Res 1989; 17: 6167-6179. (Pubitemid 19198596)
20. Boddy MN, Duprez E, Borden KL, Freemont PS. Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies. J Cell Sci 1997; 110 (Part 18): 2197-2205. (Pubitemid 27448364)
21. Tezel G, Nagasaka T, Iwahashi N, Asai N, Iwashita T, Sakata K et al. Different nuclear/cytoplasmic distributions of RET finger protein in different cell types. Pathol Int 1999; 49: 881-886.
22. Shimono Y, Murakami H, Kawai K, Wade PA, Shimokata K, Takahashi M. Mi-2 beta associates with BRG1 and RET finger protein at the distinct regions with transcriptional activating and repressing abilities. J Biol Chem 2003; 278: 51638-51645. (Pubitemid 38020409)
23. Matsuura T, Shimono Y, Kawai K, Murakami H, Urano T, Niwa Y et al. PIAS proteins are involved in the SUMO-1 modification, intracellular translocation and transcriptional repressive activity of RET finger protein. Exp Cell Res 2005; 308: 65-77. (Pubitemid 40984762)
24. Krutzfeldt M, Ellis M, Weekes DB, Bull JJ, Eilers M, Vivanco MD et al. Selective ablation of retinoblastoma protein function by the RET finger protein. Mol Cell 2005; 18: 213-224.
25. Fukushige S, Kondo E, Gu Z, Suzuki H, Horii A. RET finger protein enhances MBD2-and MBD4-dependent transcriptional repression. Biochem Biophys Res Commun 2006; 351: 85-92. (Pubitemid 44635410)
26. Townson SM, Kang K, Lee AV, Oesterreich S. Novel role of the RET finger protein in estrogen receptor-mediated transcription in MCF-7 cells. Biochem Biophys Res Commun 2006; 349: 540-548. (Pubitemid 44349140)
27. Zha J, Han KJ, Xu LG, HeW, Zhou Q, Chen D et al. The Ret finger protein inhibits signaling mediated by the noncanonical and canonical IkappaB kinase family members. J Immunol 2006; 176: 1072-1080. (Pubitemid 43099708)
28. Cao T, Borden KL, Freemont PS, Etkin LD. Involvement of the rfp tripartite motif in protein-protein interactions and subcellular distribution. J Cell Sci 1997; 110 (Part 14): 1563-1571. (Pubitemid 27338744)
29. Ishido M, Kami K, Masuhara M. Localization of MyoD, myogenin and cell cycle regulatory factors in hypertrophying rat skeletal muscles. Acta Physiol Scand 2004; 180: 281-289. (Pubitemid 38299639)
30. Bloor AJ, Kotsopoulou E, Hayward P, Champion BR, Green AR. RFP represses transcriptional activation by bHLH transcription factors. Oncogene 2005; 24: 6729-6736. (Pubitemid 41487032)
31. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83-90. (Pubitemid 27202654)
32. Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002; 296: 1486-1488. (Pubitemid 34553097)
33. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002; 420: 418-421. (Pubitemid 35415652)
34. Ohsawa Y, Hagiwara H, Nakatani M, Yasue A, Moriyama K, Murakami T et al. Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition. J Clin Invest 2006; 116: 2924-2934. (Pubitemid 44684477)
35. Tsukamoto H, Kato T, Enomoto A, Nakamura N, Shimono Y, Jijiwa M et al. Expression of Ret finger protein correlates with outcomes in endometrial cancer. Cancer Sci 2009; 100: 1895-1901.
36. Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression. Pathol Res Pract 2009; 205: 403-408.
37. Tezel G, Shimono Y, Murakumo Y, Kawai K, Fukuda T, Iwahashi N et al. Role for Oglycosylation of RFP in the interaction with enhancer of polycomb. Biochem Biophys Res Commun 2002; 290: 409-414. (Pubitemid 34694514)